General discussion, page-18243

Fair call..........a lot is unknown

What is known is that the ASX is holding us back to an extent and to negate this we have decided to go and play on a much bigger platform (Nasdaq)..........IMO this is just another option we have and one that could surprise to the upside, albeit, it might take many months for that to occur. Conversely it might never work but God loves a trier, and we will try. How will US investors see our products and timelines and hopeful FDA approvals is yet to be understood. Joel and the rest of the executive team would have discussed this at length and completed some extensive dd on this move.

Only guarantees these days is death and taxes but as investors in the BIOTECH sector we come with big dreams, big expectations and big kahunas...........We try and improve humanity by developing products that can serve ever-growing unmet medical needs. Stats are always going to be against us as more fail than succeed but I am only preaching to believers here who want to be part of something spectacular and something that comes with so many risks attached.

Understanding risk here is vital as is patience that will be required but we trend-setters are giving this a red-hot go and may our dreams come true

GLTAH and including the fence-sitters considering jumping on this biotech train while there are still cheap seats available